Medical AI Overlooks Real Treatment Outcomes, Limiting Potential

Medical artificial intelligence has made significant strides in diagnostic and prognostic tasks, which are crucial for guiding treatment decisions. However, a recent position paper highlights a critical gap: the understanding and evaluation of the treatments themselves are often based on human interpretations and published guidelines rather than direct, real-world patient outcomes. This reliance on secondary data, such as biomedical literature and clinical practice guidelines, rather than primary observational databases and randomized trial results, limits the true potential of medical AI. The paper contends that this neglect is already causing deficiencies in both cutting-edge AI models and established benchmarks. To address this, the authors advocate for a substantial integration of actual treatment outcome data into both the training and evaluation phases of medical AI systems. They emphasize that improving these real-world patient outcomes should be the ultimate goal driving all medical AI development, shifting the focus from diagnostic accuracy alone to the holistic impact on patient care.